Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences Limited has informed the stock exchanges that its management will participate in an investor conference with Capital Group on Thursday, March 19, 2026, in Mumbai. The meeting is scheduled as an in-person one-on-one interaction at 9:30 AM, with Mr. Krishnakumar Vaidyanathan representing the company. The disclosure was filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. The company clarified that no unpublished price sensitive information (UPSI) will be shared during the meeting, with discussions limited to publicly available documents.
This is a routine regulatory disclosure about an investor engagement and generally has no direct material impact on the stock price. It signals continued institutional investor outreach by the company's management.